Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB

The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of biochemistry 2004-08, Vol.271 (16), p.3360-3367
Hauptverfasser: Belorgey, Didier, Sharp, Lynda K, Crowther, Damian C, Onda, Maki, Johansson, Jan, Lomas, David A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3367
container_issue 16
container_start_page 3360
container_title European journal of biochemistry
container_volume 271
creator Belorgey, Didier
Sharp, Lynda K
Crowther, Damian C
Onda, Maki
Johansson, Jan
Lomas, David A
description The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.
doi_str_mv 10.1111/j.1432-1033.2004.04270.x
format Article
fullrecord <record><control><sourceid>pubmed_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_584528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15291813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c294t-4938a396891a54b774c7f2400eb15ca70634d7000e5f4c2c16681635009605853</originalsourceid><addsrcrecordid>eNpFkd1O3DAQhS1EVRbaV0C-LBdJx79JuKMIChKilaDXljeZtF7yY9mmZd-lD1uHXVHfeDRzzpFmPkIog5Ll93lTMil4wUCIkgPIEiSvoHw5IKu3wSFZATBZ8EbpI3Ic4wYAdKOr9-SIKd6wmokV-XuPz2GOGLyb6Pc5pMFOHf30gEHxi_DzjLpIU7DeY0dtpHaibrJtcr8xFwnDiJ2zCWn6ZRPNOtcNW9rPYYzUz8N2xBDPqRv94Fqb3DzFZZjVSNG7AX3c0oi4pL42OxxxSs7S66v72y8fyLveDhE_7v8T8uP66vHyprj79vX28uKuaHkjUyEbUVvR6LphVsl1Vcm26rkEwDVTra1AC9lVeXtUvWx5y7SumRYKoNGgaiVOSLHLjX_QP6-ND260YWtm68y-9ZQrNKqWitdZX-_0bT5dDNi_ORiYBZDZmIWDWTiYBZB5BWResvV0Z82h-Xb_jXsi4h_XMI39</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Belorgey, Didier ; Sharp, Lynda K ; Crowther, Damian C ; Onda, Maki ; Johansson, Jan ; Lomas, David A</creator><creatorcontrib>Belorgey, Didier ; Sharp, Lynda K ; Crowther, Damian C ; Onda, Maki ; Johansson, Jan ; Lomas, David A</creatorcontrib><description>The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.</description><identifier>ISSN: 0014-2956</identifier><identifier>EISSN: 1432-1033</identifier><identifier>DOI: 10.1111/j.1432-1033.2004.04270.x</identifier><identifier>PMID: 15291813</identifier><language>eng</language><publisher>England</publisher><subject>Amino Acid Substitution - genetics ; Arginine - genetics ; Arginine - metabolism ; Biopolymers - chemistry ; Biopolymers - genetics ; Biopolymers - metabolism ; Catalysis ; Circular Dichroism ; Dementia - genetics ; Dementia - metabolism ; Epilepsy - genetics ; Epilepsy - metabolism ; Humans ; Hydrolysis ; Inclusion Bodies - metabolism ; Models, Molecular ; Neuropeptides - chemistry ; Neuropeptides - classification ; Neuropeptides - genetics ; Neuropeptides - metabolism ; Neuroserpin ; Protein Denaturation - drug effects ; Protein Folding ; Protein Structure, Tertiary ; Serine - genetics ; Serpins - chemistry ; Serpins - classification ; Serpins - genetics ; Serpins - metabolism ; Spectrometry, Fluorescence ; Temperature ; Tissue Plasminogen Activator - antagonists &amp; inhibitors ; Tissue Plasminogen Activator - metabolism ; Urea - pharmacology</subject><ispartof>European journal of biochemistry, 2004-08, Vol.271 (16), p.3360-3367</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c294t-4938a396891a54b774c7f2400eb15ca70634d7000e5f4c2c16681635009605853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15291813$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:110390821$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Belorgey, Didier</creatorcontrib><creatorcontrib>Sharp, Lynda K</creatorcontrib><creatorcontrib>Crowther, Damian C</creatorcontrib><creatorcontrib>Onda, Maki</creatorcontrib><creatorcontrib>Johansson, Jan</creatorcontrib><creatorcontrib>Lomas, David A</creatorcontrib><title>Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB</title><title>European journal of biochemistry</title><addtitle>Eur J Biochem</addtitle><description>The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.</description><subject>Amino Acid Substitution - genetics</subject><subject>Arginine - genetics</subject><subject>Arginine - metabolism</subject><subject>Biopolymers - chemistry</subject><subject>Biopolymers - genetics</subject><subject>Biopolymers - metabolism</subject><subject>Catalysis</subject><subject>Circular Dichroism</subject><subject>Dementia - genetics</subject><subject>Dementia - metabolism</subject><subject>Epilepsy - genetics</subject><subject>Epilepsy - metabolism</subject><subject>Humans</subject><subject>Hydrolysis</subject><subject>Inclusion Bodies - metabolism</subject><subject>Models, Molecular</subject><subject>Neuropeptides - chemistry</subject><subject>Neuropeptides - classification</subject><subject>Neuropeptides - genetics</subject><subject>Neuropeptides - metabolism</subject><subject>Neuroserpin</subject><subject>Protein Denaturation - drug effects</subject><subject>Protein Folding</subject><subject>Protein Structure, Tertiary</subject><subject>Serine - genetics</subject><subject>Serpins - chemistry</subject><subject>Serpins - classification</subject><subject>Serpins - genetics</subject><subject>Serpins - metabolism</subject><subject>Spectrometry, Fluorescence</subject><subject>Temperature</subject><subject>Tissue Plasminogen Activator - antagonists &amp; inhibitors</subject><subject>Tissue Plasminogen Activator - metabolism</subject><subject>Urea - pharmacology</subject><issn>0014-2956</issn><issn>1432-1033</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkd1O3DAQhS1EVRbaV0C-LBdJx79JuKMIChKilaDXljeZtF7yY9mmZd-lD1uHXVHfeDRzzpFmPkIog5Ll93lTMil4wUCIkgPIEiSvoHw5IKu3wSFZATBZ8EbpI3Ic4wYAdKOr9-SIKd6wmokV-XuPz2GOGLyb6Pc5pMFOHf30gEHxi_DzjLpIU7DeY0dtpHaibrJtcr8xFwnDiJ2zCWn6ZRPNOtcNW9rPYYzUz8N2xBDPqRv94Fqb3DzFZZjVSNG7AX3c0oi4pL42OxxxSs7S66v72y8fyLveDhE_7v8T8uP66vHyprj79vX28uKuaHkjUyEbUVvR6LphVsl1Vcm26rkEwDVTra1AC9lVeXtUvWx5y7SumRYKoNGgaiVOSLHLjX_QP6-ND260YWtm68y-9ZQrNKqWitdZX-_0bT5dDNi_ORiYBZDZmIWDWTiYBZB5BWResvV0Z82h-Xb_jXsi4h_XMI39</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Belorgey, Didier</creator><creator>Sharp, Lynda K</creator><creator>Crowther, Damian C</creator><creator>Onda, Maki</creator><creator>Johansson, Jan</creator><creator>Lomas, David A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20040801</creationdate><title>Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB</title><author>Belorgey, Didier ; Sharp, Lynda K ; Crowther, Damian C ; Onda, Maki ; Johansson, Jan ; Lomas, David A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c294t-4938a396891a54b774c7f2400eb15ca70634d7000e5f4c2c16681635009605853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Amino Acid Substitution - genetics</topic><topic>Arginine - genetics</topic><topic>Arginine - metabolism</topic><topic>Biopolymers - chemistry</topic><topic>Biopolymers - genetics</topic><topic>Biopolymers - metabolism</topic><topic>Catalysis</topic><topic>Circular Dichroism</topic><topic>Dementia - genetics</topic><topic>Dementia - metabolism</topic><topic>Epilepsy - genetics</topic><topic>Epilepsy - metabolism</topic><topic>Humans</topic><topic>Hydrolysis</topic><topic>Inclusion Bodies - metabolism</topic><topic>Models, Molecular</topic><topic>Neuropeptides - chemistry</topic><topic>Neuropeptides - classification</topic><topic>Neuropeptides - genetics</topic><topic>Neuropeptides - metabolism</topic><topic>Neuroserpin</topic><topic>Protein Denaturation - drug effects</topic><topic>Protein Folding</topic><topic>Protein Structure, Tertiary</topic><topic>Serine - genetics</topic><topic>Serpins - chemistry</topic><topic>Serpins - classification</topic><topic>Serpins - genetics</topic><topic>Serpins - metabolism</topic><topic>Spectrometry, Fluorescence</topic><topic>Temperature</topic><topic>Tissue Plasminogen Activator - antagonists &amp; inhibitors</topic><topic>Tissue Plasminogen Activator - metabolism</topic><topic>Urea - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belorgey, Didier</creatorcontrib><creatorcontrib>Sharp, Lynda K</creatorcontrib><creatorcontrib>Crowther, Damian C</creatorcontrib><creatorcontrib>Onda, Maki</creatorcontrib><creatorcontrib>Johansson, Jan</creatorcontrib><creatorcontrib>Lomas, David A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>European journal of biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belorgey, Didier</au><au>Sharp, Lynda K</au><au>Crowther, Damian C</au><au>Onda, Maki</au><au>Johansson, Jan</au><au>Lomas, David A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB</atitle><jtitle>European journal of biochemistry</jtitle><addtitle>Eur J Biochem</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>271</volume><issue>16</issue><spage>3360</spage><epage>3367</epage><pages>3360-3367</pages><issn>0014-2956</issn><eissn>1432-1033</eissn><abstract>The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene. We have shown a correlation between the predicted effect of the mutation and the number of intracerebral inclusions, and an inverse relationship with the age of onset of disease. Our previous work has shown that the intraneuronal inclusions in FENIB result from the sequential interaction between the reactive centre loop of one neuroserpin molecule with beta-sheet A of the next. We show here that neuroserpin Portland (Ser52Arg), which causes a severe form of FENIB, also forms loop-sheet polymers but at a faster rate, in keeping with the more severe clinical phenotype. The Portland mutant has a normal unfolding transition in urea and a normal melting temperature but is inactive as a proteinase inhibitor. This results in part from the reactive loop being in a less accessible conformation to bind to the target enzyme, tissue plasminogen activator. These results, with those of the CD analysis, are in keeping with the reactive centre loop of neuroserpin Portland being partially inserted into beta-sheet A to adopt a conformation similar to an intermediate on the polymerization pathway. Our data provide an explanation for the number of inclusions and the severity of dementia in FENIB associated with neuroserpin Portland. Moreover the inactivity of the mutant may result in uncontrolled activity of tissue plasminogen activator, and so explain the epileptic seizures seen in individuals with more severe forms of the disease.</abstract><cop>England</cop><pmid>15291813</pmid><doi>10.1111/j.1432-1033.2004.04270.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2956
ispartof European journal of biochemistry, 2004-08, Vol.271 (16), p.3360-3367
issn 0014-2956
1432-1033
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_584528
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Amino Acid Substitution - genetics
Arginine - genetics
Arginine - metabolism
Biopolymers - chemistry
Biopolymers - genetics
Biopolymers - metabolism
Catalysis
Circular Dichroism
Dementia - genetics
Dementia - metabolism
Epilepsy - genetics
Epilepsy - metabolism
Humans
Hydrolysis
Inclusion Bodies - metabolism
Models, Molecular
Neuropeptides - chemistry
Neuropeptides - classification
Neuropeptides - genetics
Neuropeptides - metabolism
Neuroserpin
Protein Denaturation - drug effects
Protein Folding
Protein Structure, Tertiary
Serine - genetics
Serpins - chemistry
Serpins - classification
Serpins - genetics
Serpins - metabolism
Spectrometry, Fluorescence
Temperature
Tissue Plasminogen Activator - antagonists & inhibitors
Tissue Plasminogen Activator - metabolism
Urea - pharmacology
title Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A15%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroserpin%20Portland%20(Ser52Arg)%20is%20trapped%20as%20an%20inactive%20intermediate%20that%20rapidly%20forms%20polymers:%20implications%20for%20the%20epilepsy%20seen%20in%20the%20dementia%20FENIB&rft.jtitle=European%20journal%20of%20biochemistry&rft.au=Belorgey,%20Didier&rft.date=2004-08-01&rft.volume=271&rft.issue=16&rft.spage=3360&rft.epage=3367&rft.pages=3360-3367&rft.issn=0014-2956&rft.eissn=1432-1033&rft_id=info:doi/10.1111/j.1432-1033.2004.04270.x&rft_dat=%3Cpubmed_swepu%3E15291813%3C/pubmed_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15291813&rfr_iscdi=true